nach oben

Endocrine

Erschienen in:

05.06.2018 | Endocrine Surgery

Histology-proven recurrence in the lateral or central neck after systematic neck dissection for medullary thyroid cancer

verfasst von: Andreas Machens, Kerstin Lorenz, Henning Dralle

Erschienen in: Endocrine | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To delineate risk factors for, and examine temporal patterns of, histology-proven recurrent medullary thyroid cancer (MTC) after compartment-oriented surgery.

Methods

Multivariate Cox regression on overall, node, and soft tissue infiltrate recurrence per previously dissected neck compartment.

Results

Mean follow-up for the 203 (and 158) patients with central (and ipsilateral lateral) neck dissection was 56.1 months. On multivariate Cox regression, tumor size > 20 mm predicted overall and node recurrence in the central neck, whereas extranodal growth predicted overall and node recurrence in the ipsilateral lateral neck. Extrathyroidal extension alone predicted soft tissue infiltrate recurrence in the central neck, and extranodal growth alone soft tissue infiltrate recurrence in the ipsilateral lateral neck. When analyses were restricted to patients not biochemically cured after initial surgery, only extranodal growth predicted overall and node recurrence in the dissected neck compartments.

Conclusions

Patients not biochemically cured, specifically those with extranodal growth at the initial operation, carry greater risks of node recurrence.

G.C. Chong, O.H. Beahrs, G.W. Sizemore, L.H. Woolner, Medullary carcinoma of the thyroid gland. Cancer 35, 695–704 (1975)CrossRefPubMed

L.E. Tisell, G. Hansson, S. Jansson, H. Salander, Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 99, 60–66 (1986)PubMed

H. Dralle, I. Damm, G.F.W. Scheumann, J. Kotzerke, E. Kupsch, H. Geerlings, R. Pichlmayr, Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg. Today 24, 112–121 (1994)CrossRefPubMed

J.F. Moley, M.K. DeBenedetti, Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. Ann. Surg. 229, 880–887 (1999). Discussion 887–888 (1999)CrossRefPubMedPubMedCentral

A. Machens, H. Dralle, Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J. Clin. Endocrinol. Metab. 95, 2655–2663 (2010)CrossRefPubMed

A. Machens, U. Schneyer, H.J. Holzhausen, H. Dralle, Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J. Clin. Endocrinol. Metab. 90, 2029–2034 (2005)CrossRefPubMed

S. Szakall Jr., O. Esik, G. Bajzik, I. Repa, G. Dabasi, I. Sinkovics, P. Agoston, L. Tron, 18F-FDG PET detection of lymph node metastases in medullary thyroid carcinoma. J. Nucl. Med. 43, 66–71 (2002)PubMed

S.C. Ong, H. Schoder, S.G. Patel, I.M. Tabangay-Lim, I. Doddamane, M. Gonen, A.R. Shaha, R.M. Tuttle, J.P. Shah, S.M. Larson, Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels. J. Nucl. Med. 48, 501–507 (2007)CrossRefPubMed

S. Hoegerle, C. Altehoefer, N. Ghanem, I. Brink, E. Moser, E. Nitzsche, 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur. J. Nucl. Med. 28, 64–71 (2001)CrossRefPubMed

10.

H.H. Verbeek, J.T. Plukker, K.P. Koopmans, J.W. de Groot, R.M. Hofstra, A.C. Muller Kobold, A.N. van der Horst-Schrivers, A.H. Brouwers, T.P. Links, Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma. J. Nucl. Med. 53, 1863–1871 (2012)CrossRefPubMed

11.

M. Beheshti, S. Pocher, R. Vali, P. Waldenberger, G. Broinger, M. Nader, S. Kohlfurst, C. Pirich, H. Dralle, W. Langsteger, The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT. Eur. Radiol. 19, 1425–1434 (2009)CrossRefPubMed

12.

M. Luster, W. Karges, K. Zeich, S. Pauls, F.A. Verburg, H. Dralle, G. Glatting, A.K. Buck, C. Solbach, B. Neumaier, S.N. Reske, F.M. Mottaghy, Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid 20, 527–533 (2010)CrossRefPubMed

13.

S. Kauhanen, C. Schalin-Jantti, M. Seppanen, S. Kajander, S. Virtanen, J. Schildt, I. Lisinen, A. Ahonen, I. Heiskanen, M. Vaisanen, J. Arola, P. Korsoff, T. Ebeling, T. Sane, H. Minn, M.J. Valimaki, P. Nuutila, Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer. J. Nucl. Med. 52, 1855–1863 (2011)CrossRefPubMed

14.

G. Treglia, P. Castaldi, M.F. Villani, G. Perotti, C. de Waure, A. Filice, V. Ambrosini, N. Cremonini, M. Santimaria, A. Versari, S. Fanti, A. Giordano, V. Rufini, Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. Eur. J. Nucl. Med. Mol. Imaging 39, 569–580 (2012)CrossRefPubMed

15.

P. Hartzband, J. Groopman, There is more to life than death. N. Engl. J. Med. 367, 987–989 (2012)CrossRefPubMed

16.

E. Kandil, M.M. Gilson, H.H. Alabbas, A.P. Tufaro, A. Dackiw, R.P. Tufano, Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer. Ann. Surg. Oncol. 18, 1028–1034 (2011)CrossRefPubMed

17.

E. Kebebew, K. Shoichi, Q.Y. Duh, O. Clark, Long-term results of reoperations and localization studies in patients with persistent or recurrent medullary thyroid cancer. Arch. Surg. 135, 895–901 (2000)CrossRefPubMed

18.

H. Dralle, Lymph node dissection and medullary thyroid carcinoma. Br. J. Surg. 89, 1073–1075 (2002)CrossRefPubMed

19.

H. Dralle, T.J. Musholt, J. Schabram, T. Steinmüller, A. Frilling, D. Simon, P.E. Goretzki, B. Niederle, C. Scheuba, T. Clerici, M. Hermann, J. Kußmann, K. Lorenz, C. Nies, P. Schabram, A. Trupka, A. Zielke, W. Karges, M. Luster, K.W. Schmid, D. Vordermark, H.J. Schmoll, R. Mühlenberg, O. Schober, H. Rimmele, A. Machens; German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V., German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch. Surg. 398, 347–375 (2013)

20.

F.L. Greene, D.L. Page, I.D. Fleming, A. Fritz, C.M. Balch, D.G. Haller, M. Morrow (eds) AJCC Cancer Staging Manual, 6th edn. (Springer, New York, 2002)

21.

C. Hedinger, E.D. Williams, L.H. Sobin. in International Histological Classification of Tumours, World Health Organization. (Springer-Verlag: Berlin, Germany, 1988)

22.

R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng eds. World Health Organization classification of tumours: Pathology and genetics of tumours of endocrine organs. (IARC Press, Lyon, France, 2004)

23.

J.M. Bland, D.G. Altman, Multiple significance tests: the Bonferroni method. Br. Med. J. 310, 170 (1995)CrossRef

24.

E.L. Kaplan, P. Meier, Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457–481 (1958)CrossRef

25.

R. Peto, M.C. Pike, P. Armitage, N.E. Breslow, D.R. Cox, S.V. Howard, N. Mantel, K. McPherson, J. Peto, P.G. Smith, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer 35, 1–39 (1977)CrossRefPubMedPubMedCentral

26.

D.R. Cox, Regression models and life tables. J. R. Stat. Soc. 34, 187–220 (1972)

27.

A. Machens, S. Hauptmann, H. Dralle, Referral bias in thyroid cancer surgery: direction and magnitude. Eur. J. Surg. Oncol. 34, 556–562 (2008)CrossRefPubMed

28.

S.C. Lindsey, I. Ganly, F. Palmer, R.M. Tuttle, Response to initial therapy predicts clinical outcomes in medullary thyroid cancer. Thyroid 25, 242–249 (2015)CrossRefPubMed

29.

J.H. Yang, S.C. Lindsey, C.P. Camacho, F.O. Valente, F. Germano-Neto, A.L. Machado, M.C. Mamone, F. Brodskyn, R.P. Biscolla, R.M. Tuttle, M.R. Dias-da-Silva, R.M. Maciel, Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer. Clin. Endocrinol. 83, 938–942 (2015)CrossRef

30.

J. Barbet, L. Campion, F. Kraeber-Bodéré, J.F. Chatal; GTE Study Group, Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 90, 6077–6084 (2005)CrossRefPubMed

31.

J.A. Meijer, S. le Cessie, W.B. van den Hout, J. Kievit, J.W. Schoones, J.A. Romijn, J.W. Smit, Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta-analysis. Clin. Endocrinol. 72, 534–542 (2010)CrossRef

Titel: Histology-proven recurrence in the lateral or central neck after systematic neck dissection for medullary thyroid cancer
verfasst von: Andreas Machens
Kerstin Lorenz
Henning Dralle
Publikationsdatum: 05.06.2018
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1625-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Histology-proven recurrence in the lateral or central neck after systematic neck dissection for medullary thyroid cancer

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Patients’ knowledge about the outcomes of thyroid biopsy: a patient survey

Does the ACR TI-RADS scoring allow us to safely avoid unnecessary thyroid biopsy? single center analysis in a large cohort

Giant pituitary adenoma: histological types, clinical features and therapeutic approaches

Pituitary in black—hypopituitarism secondary to hemosiderosis

Serum calcitonin gene-related peptide facilitates adipose tissue lipolysis during exercise via PIPLC/IP3 pathways

Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin